Its further alignment with advanced vascular assessments (e.g., pulse wave velocity, intima-media thickness) to improve early prediction of unstable cardiovascular phenotypes supports the use of CRP/mCRP as an early detector of preclinical endothelial dysfunction and vascular remodeling, preceding overt atherosclerosis or ischemic events. The gene discussed is CRP; the disease is endothelial dysfunction.